← FDA Drug Approvals (Drugs@FDA)

SOOLANTRA

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2014-12-19

Drug application

FDA Application #

NDA206255

Application type

New Drug Application

Brand name

SOOLANTRA

Generic name

IVERMECTIN

Active ingredients

IVERMECTIN

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

GALDERMA LABS LP

Manufacturer

Galderma Laboratories, L.P.

First approval

2014-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown